Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,385 | 90,285 | 71,625 | 103,147 | 86,707 |
| Receivables | 137,673 | 109,726 | 99,412 | 49,999 | 50,140 |
| Inventories | 196,667 | 191,464 | 172,188 | 170,235 | 171,801 |
| TOTAL | $402,655 | $399,563 | $351,814 | $331,410 | $318,193 |
| Non-Current Assets | |||||
| PPE Net | 69,509 | 57,501 | 57,710 | 54,707 | 53,694 |
| Intangibles | 4,021 | 4,057 | 3,982 | 3,990 | 4,015 |
| Other Non-Current Assets | 92,502 | 97,259 | 97,063 | 98,571 | 14,716 |
| TOTAL | $166,032 | $158,817 | $158,755 | $157,268 | $72,425 |
| Total Assets | $568,687 | $558,380 | $510,569 | $488,678 | $390,618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,021 | 29,769 | 20,607 | 20,219 | 16,020 |
| Accrued Expenses | 28,827 | 43,902 | 31,560 | 34,105 | 27,535 |
| TOTAL | $56,490 | $74,941 | $53,498 | $55,542 | $44,891 |
| Non-Current Liabilities | |||||
| Long Term Debt | 70,084 | 73,397 | 72,527 | 72,337 | 101,326 |
| Deferred Revenues | N/A | 143 | 143 | N/A | 143 |
| Other Non-Current Liabilities | 90 | 940 | 1,315 | 1,673 | 2,063 |
| TOTAL | $81,011 | $85,114 | $83,652 | $84,118 | $113,837 |
| Total Liabilities | $137,501 | $160,055 | $137,150 | $139,660 | $158,728 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 237,998 | 238,631 | 238,734 | 237,615 | 236,390 |
| Common Shares | 24 | 24 | 24 | 24 | 24 |
| Retained earnings | -211,032 | -247,460 | -281,679 | -308,583 | -420,479 |
| Other shareholders' equity | -188 | -148 | 0 | 0 | 0 |
| TOTAL | $431,186 | $398,325 | $373,419 | $349,018 | $231,890 |
| Total Liabilities And Equity | $568,687 | $558,380 | $510,569 | $488,678 | $390,618 |